Jan 29,2024 TOP STORY

Cognito Therapeutics raises $35M Series B extension

Obviously there's no known cure for Alzheimer’s right now but Cognito Therapeutics is looking to finally find one with its medical device that delivers both visual and auditory stimulation for the treatment for Alzheimer’s, and other neurodegenerative diseases. The company announced an extension of the Series B round they raised $73 million in March 2023 from FoundersX, Morningside, Alzheimer’s Drug Discovery Foundation, IAG Capital, Starbloom, WSGR; this brings the total round to $108 million and its total funding to $128 million. Since raising its last funding, Cognito started its Ph3/Pivotal study for the treatment of Alzheimer’s Disease, called HOPE, which has over 250 patients enrolled so far. "We have made great progress with study enrollment. We expect to have the study fully enrolled this summer with top-line readout and FDA submission expected in 2H 2025," Brent Vaughan, CEO of Cognito Therapeutics, told.

FUNDING SERIES B

#connected device

View Analyst & Ambassador Comments
Go to original news
Dec 13,2023

Addiction Startup PursueCare Raises $20M

Virtual substance use disorder (SUD) provider PursueCare netted $20 million in a series B fundraising round. T.Rx Capital and Yamaha Motor Ventures led the funding round with participation from Seyen Capital and OCA Ventures. The company has also announced the acquisition of three software products of Pear Therapeutics following its bankruptcy.

FUNDING SERIES B

#cbt

View Analyst & Ambassador Comments
Go to original news
Oct 24,2023 TOP STORY

Signos Announces Series B Funding Round of $20 Million

Signos, a metabolic health platform that utilizes a unique AI-engine with a continuous glucose monitor (CGM) to offer real-time data and recommendations for healthy weight management, has announced a successful $20 million Series B funding round. The round was led by Cheyenne Ventures and GV (Google Ventures), with additional investments from Dexcom Ventures and Samsung. It will enable Signos to expand its team, extend its platform and conduct further research on metabolic health. The Signos app allows users to log their food intake and exercise levels, enabling the AI platform to learn how an individual’s metabolism responds to various foods and fitness patterns. This information then provides personalized, data-driven recommendations based on an individual’s unique metabolic profile.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Jul 16,2018

AI Healthcare Company Lunit Raises $15 Million in Series B Funding Round

Lunit, an AI healthcare startup company that uses deep-learning technology in medical imaging, today announced its Series B raise of $15 million. The round was led by Intervest, joined by Softbank Ventures, Kakao Ventures, Mirae Asset Venture Investment, KT Investment(Korea Telecom) and others—a total of 7 international venture capital investors. “The investment and support from the investors were key to our development of medical AI and its global recognition,” said Anthony Paek, CEO of Lunit. “We will now accelerate the market release of our developed products and step up to become a company that can help alleviate sufferings of patients and families from various diseases.”

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Aug 22,2023

Value-based oncology platform Thyme Care clinches $60M to expand in new markets

Thyme Care, a value-based oncology platform, has raised $60 million in a series B round. The round was co-led by Town Hall Ventures and Foresite Capital with participation from existing investors Andreessen Horowitz Bio + Health, AlleyCorp, Casdin Capital and Frist Cressey Ventures. The funding will be used to accelerate partnerships in new markets and expand its cancer care support services. Thyme Care also plans to broaden its roster of oncology and healthcare experts and announce additional partnerships in the coming months. The latest capital brings the company’s total raised to more than $80 million. Thyme Care combines tech with high-touch patient care to support care journeys. Powered by a team of nurse practitioners, oncology nurses and resource specialists, the company aims to help members better understand their diagnosis, manage and address symptoms and quickly connect them to care with its platform, Thyme Box.

FUNDING SERIES B

#virtual care

View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Lark Health Raises $20M in Series B

Lark Health, a provider of chronic disease prevention and management programs, closed a $55 million Series C funding round as well as a $15 million venture debt credit facility. The company’s Series A funding round in 2013 raised about $11 million, and its Series B funding round raised approximately $20 million in 2017, Lark Health CEO Julia Hu said.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 02,2023

Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Mar 22,2023

Cognito beams up $73M for study of light-and-sound neuromod therapy to treat Alzheimer's

Cognito Therapeutics has secured $73 million in a series B funding round, led by FoundersX Ventures, to advance its light-and-sound neuromodulation headset technology, which is being studied for its potential to treat Alzheimer's disease. The headset combines personalized gamma-frequency light and audio stimulation to stimulate gamma oscillations, a mechanism that promotes stronger brain connections and efficient removal of neuron-destroying proteins. Cognito's approach differs from other Alzheimer's treatments that target proteins like beta-amyloid and tau. The funding will support a pivotal study of the technology, which began last month, and expanding the team. Early trial results have shown promise

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 02,2023

Hygieia Extends Series B Round to $22 Million with Participation from Strategic Investors

Hygieia, a digital therapeutics company for insulin therapy, is extending its Series B funding round to $22 million with a lead investment from Firstime Ventures and additional investment from two strategic partners.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Apr 03,2023

Wellth raises $20M for health app with financial rewards

Wellth, a digital health startup that offers small financial rewards for completing health-related tasks, scooped up $20 million in Series B funding. Wellth works with insurers, providers and employers to offer an app that reminds users about daily health behaviors, like taking medications or monitoring blood glucose. When patients take a photo confirming they've completed tasks, they receive small financial incentives. The company includes services for mental health concerns, cardiovascular disease, heart failure, diabetes, cancer, chronic kidney disease and COPD or asthma.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES B